本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

enVVeno Medical Corp.

0.3711
-0.0489-11.64%
成交量:206.06万
成交额:78.33万
市值:750.22万
市盈率:-0.34
高:0.3964
开:0.3700
低:0.3600
收:0.4200
52周最高:5.62
52周最低:0.3600
股本:2,021.62万
流通股本:1,908.56万
量比:1.96
换手率:10.80%
股息:- -
股息率:- -
每股收益(TTM):-1.0815
每股收益(LYR):-1.2728
净资产收益率:-57.19%
总资产收益率:-35.12%
市净率:0.25
市盈率(LYR):-0.29

数据加载中...

2021/08/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/26

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/03/31

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/24

重要事件披露

8-K - Current report
2021/02/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

重要事件披露

8-K - Current report
2021/02/05

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/02/05

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/02/05

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/05

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/04

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/03

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/02/03

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/03

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/29

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/28

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/01/20

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals